Cross Country Healthcare (NASDAQ: CCRN) sets 2026 meeting and proposal deadlines
Rhea-AI Filing Summary
Cross Country Healthcare, Inc. has set May 11, 2026 as the date for its virtual-only 2026 Annual Meeting of Stockholders. Details on the meeting time and website will appear in the proxy statement, which is expected to be made available on or about March 31, 2026.
Stockholder proposals for inclusion in the proxy statement under Rule 14a-8 must reach the company’s principal executive office by the close of business on March 11, 2026. Under the company’s bylaws, notices to propose other business or nominate directors must be delivered by February 10, 2026.
To use the universal proxy rules for director nominees other than the company’s, stockholders must provide the information required by Rule 14a-19 by March 12, 2026. All materials are to be sent to the Corporate Secretary at the Boca Raton, Florida headquarters.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 5.08, 8.01
2 items
Item 5.08
Shareholder Director Nominations
Governance
Shareholder nominations for board of directors under proxy access rules. Rarely used -- the underlying SEC rule was vacated.
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
When will Cross Country Healthcare (CCRN) hold its 2026 annual meeting?
Cross Country Healthcare plans to hold its 2026 Annual Meeting of Stockholders on May 11, 2026 as a virtual-only meeting. The specific time and website will be provided in the company’s proxy statement, expected to be available around March 31, 2026.
What is the deadline for CCRN stockholder proposals under Rule 14a-8 for 2026?
To be included in the 2026 proxy statement under Rule 14a-8, Cross Country Healthcare must receive stockholder proposals and supporting statements by the close of business on March 11, 2026 at its principal executive office in Boca Raton, Florida.
When must CCRN stockholders submit director nominations or other business for the 2026 meeting?
Under Cross Country Healthcare’s amended and restated bylaws, stockholders proposing other business or nominating directors for the 2026 Annual Meeting must deliver a written notice with required information no later than February 10, 2026 to the company’s principal executive office.
How do CCRN stockholders comply with universal proxy rules for 2026 director nominees?
Stockholders intending to solicit proxies for director nominees other than Cross Country Healthcare’s nominees must provide the information required by Exchange Act Rule 14a-19 by March 12, 2026. This notice is in addition to meeting bylaw and Rule 14a-8 requirements where applicable.
Where should Cross Country Healthcare (CCRN) stockholders send 2026 meeting proposals and notices?
All stockholder proposals, bylaw notices, and universal proxy notices for Cross Country Healthcare’s 2026 Annual Meeting should be sent to the Corporate Secretary at 5201 Congress Avenue, Suite 160, Boca Raton, Florida 33487, which is the company’s principal executive office.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)January 29, 2026
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||
(Address of Principal Executive Office) (Zip Code)
(
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol Name of each exchange on which registered
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2).
Emerging growth company
Item 5.08 Shareholder Director Nominations.
To the extent applicable, the information in Item 8.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.08.
Item 8.01 Other Events.
The Board of Directors (the “Board”) of Cross Country Healthcare, Inc. (the “Company”) has determined that the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”) will be held on May 11, 2026.
The time and website address for the virtual-only 2026 Annual Meeting will be set forth in the Company’s proxy statement for the 2026 Annual Meeting, which will be made available to stockholders on or about March 31, 2026. As the date of the 2026 Annual Meeting is being advanced by more than 30 days of the anniversary of the Company’s 2025 Annual Meeting of Stockholders, the Company is hereby providing notice of the below revised deadlines for qualified stockholder proposals and stockholder nominations by means of this Current Report on Form 8-K.
In order for a stockholder proposal for the 2026 Annual Meeting to be eligible for inclusion in the Company’s proxy statement pursuant to Rule 14a-8 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Company must have received the proposal and supporting statements at its principal executive office no later than the close of business on March 11, 2026, which the Board has determined is a reasonable time before the Company begins to print and mail its proxy materials.
In accordance with the advance notice requirements set forth in the Company’s Amended and Restated Bylaws (the “Bylaws”), any stockholder (i) who wishes to propose business to be considered by the stockholders at the 2026 Annual Meeting or (ii) who wants to nominate a person for election to the Board at that meeting must provide a written notice that sets forth the specified information described in the Bylaws concerning the proposed business or nominee. The notice must be delivered no later than February 10, 2026.
In addition to satisfying the above requirements, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than the Company’s director nominees must provide notice that sets forth the information required by Rule 14a-19 of the Exchange Act no later than March 12, 2026.
All stockholder proposals and/or notices described above should be sent or delivered to the Company’s principal executive office, c/o Corporate Secretary, 5201 Congress Avenue, Suite 160, Boca Raton, Florida 33487.
A copy of the Bylaws can be obtained upon request directed to the address set forth above or is available on the Company’s website at www.crosscountryhealthcare.com. The website address included herein is an inactive textual reference only. The information contained on such website is not incorporated into this Current Report on Form 8-K.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| CROSS COUNTRY HEALTHCARE, INC. | ||||||||||||||
| Dated: | January 29, 2026 | By: | /s/ William J. Burns | |||||||||||
| Name: William J. Burns | ||||||||||||||
| Title: Executive Vice President & Chief Financial Officer | ||||||||||||||